APA

Chao T., Chu Z., Tseng L., Chiou T., Hsieh R., Wang W., Yen C., Yang M., Hsiao L., Liu J. & Chen P. (20050614). Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial. : Investigational new drugs.

Chicago

Chao Ta-Chung, Chu Zyting, Tseng Ling-Ming, Chiou Tzeon-Jye, Hsieh Ruey-Kuen, Wang Wei-Shu, Yen Chueh-Chuan, Yang Muh-Hwa, Hsiao Liang-Tsai, Liu Jin-Hwang and Chen Po-Min. 20050614. Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial. : Investigational new drugs.

Harvard

Chao T., Chu Z., Tseng L., Chiou T., Hsieh R., Wang W., Yen C., Yang M., Hsiao L., Liu J. and Chen P. (20050614). Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial. : Investigational new drugs.

MLA

Chao Ta-Chung, Chu Zyting, Tseng Ling-Ming, Chiou Tzeon-Jye, Hsieh Ruey-Kuen, Wang Wei-Shu, Yen Chueh-Chuan, Yang Muh-Hwa, Hsiao Liang-Tsai, Liu Jin-Hwang and Chen Po-Min. Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial. : Investigational new drugs. 20050614.